Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H22N2O3.ClH |
| Molecular Weight | 314.808 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C(=O)OC
InChI
InChIKey=LIWOWASNSWUKPF-UHFFFAOYSA-N
InChI=1S/C15H22N2O3.ClH/c1-5-17(6-2)10-13(18)16-14-11(3)8-7-9-12(14)15(19)20-4;/h7-9H,5-6,10H2,1-4H3,(H,16,18);1H
DescriptionSources: http://www.genome.jp/dbget-bin/www_bget?dr:D01878Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/9000257
Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01878
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/9000257
Tolycaine hydrochloride is an amide local anaesthetic included in some preparations to reduce the pain of injection. It can be used for dental injection.
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/9000257
Curator's Comment: shown to be CNS active in rats
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Small intestinal methyl leucine uptake Sources: http://www.ncbi.nlm.nih.gov/pubmed/10692555 |
|||
Target ID: Small intestinal methyl a-D-glucoside uptake Sources: http://www.ncbi.nlm.nih.gov/pubmed/10692555 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2489796 |
Palliative | Unknown Approved UseUnknown |
Sample Use Guides
Maximal dose - 250 mg for anorectal surgery
Route of Administration:
Intramuscular
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/10692555
5mM/l of Tolycaine inhibited 57% of control leucine uptake by rat jejunum
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10970
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000084638
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | |||
|
7210-92-6
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105549
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | |||
|
230-590-7
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | |||
|
23212OEY8I
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | |||
|
197869
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | |||
|
DTXSID20222424
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY | |||
|
SUB04919MIG
Created by
admin on Mon Mar 31 19:32:34 GMT 2025 , Edited by admin on Mon Mar 31 19:32:34 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD